Decoy Therapeutics Inc Com Par 0.0001 New
Research Decoy Therapeutics Inc Com Par 0.0001 New (DCOY) on Bullrun: market cap USD 782.04K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDCOY
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 782.04K
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 2.37M
- Free cash flow-USD 2.69M
Valuation Snapshot
latest market cap is USD 782.04K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | USD 12.52M | -USD 5.40M | n/a | -129.1 | USD 10.71M | USD 112.23K | USD 5.89M |
| FY2024 | USD 0 | USD 5.58M | -USD 4.53M | n/a | -69.54 | USD 2.43M | USD 221.87K | USD 1.51M |
| FY2023 | USD 0 | USD 12.54M | -USD 12.85M | n/a | -30.74 | USD 5.90M | USD 289.64K | USD 5.29M |
| FY2022 | USD 0 | -USD 31.61M | -USD 19.10M | n/a | -14.88 | USD 12.11M | n/a | USD 10.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 782.04K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 4.14M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.65M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.53M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.53M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 23.21M | n/a | n/a | n/a |
About Decoy Therapeutics Inc Com Par 0.0001 New
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Decoy Therapeutics Inc Com Par 0.0001 New's market cap?
Decoy Therapeutics Inc Com Par 0.0001 New's market capitalization is USD 782.04K.
What does Decoy Therapeutics Inc Com Par 0.0001 New do?
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs.